CarlAnthonyBlauMD

Oncology • Seattle, WA

Professor, Medicine, University of Washington School of Medicine

Join to view full profile

Dr. Blau is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Blau's full profile

Already have an account?

Office
NE Pacific St
# 1959
Seattle, WA 98195
Phone+1 206-598-4100

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 1989 - 1992
Duke University HospitalResidency, Internal Medicine, 1986 - 1989
Ohio State University College of MedicineClass of 1986

Certifications & Licensure

WA State Medical License 1989 - 2026
American Board of Internal Medicine Internal Medicine

Clinical Trials

A Crowd Sourcing Platform for Patients With Cancer Start of enrollment: 2018 Apr 26
Recruiting
Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma Start of enrollment: 2023 Mar 01
Recruiting
Roles: Contact

Publications & Presentations

PubMed

1 citations
Safety, Feasibility, and Merits of Longitudinal Molecular Testing of Multiple Metastatic Sites to Inform mTNBC Patient Treatment in the Intensive Trial of Omics in Can...
Kimberly A Burton, Elisabeth Mahen, Eric Quentin Konnick, Sibel Blau, Michael O Dorschner
JCO Precision Oncology. 2022-03-01
76 citations
Metabolic Control over mTOR-Dependent Diapause-like State.
Abdiasis M. Hussein, Yuliang Wang, Julie Mathieu, Lilyana Margaretha, Chaozhong Song
Developmental Cell. 2020-01-27
38 citations
The RareCyte® platform for next-generation analysis of circulating tumor cells.
Eric Kaldjian, Arturo Ramirez, Yao Sun, Daniel Campton, Jeffrey L. Werbin
Cytometry. Part A. 2018-12-01

Abstracts/Posters

A Multi-Omic Precision Medicine Clinical Trial in Acute Leukemia
Carl Anthony Blau, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

High Throughput Drug Screening of Leukemia Stem Cells Reveals Resistance to Standard Therapies and Sensitivity to Other Agents in Acute Myeloid Leukemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Grant Support

Modeling Mammalian GenomesNational Institute Of General Medical Sciences2011–2012
Erythropoietin Blockade For The Treatment Of CancerNational Cancer Institute2008–2011
Self Renewal And Differentiation Of Embryonic Stem CellsNational Institute Of General Medical Sciences2007–2011
Regulation Of Human Embryonic Stem Cell Self-RenewalNational Institute Of General Medical Sciences2007–2011
Cell Biosystems Firefly 3000 SystemNational Center For Research Resources2010
Receptor Specifcity In The Proliferation And Differentiation Of Stem CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2009
Receptor Specificity In The Proliferation And Differentiation Of Stem CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2008
Safety Of Chemical Inducers Of Dimmerization And Expanding GM Erythroid CellsNational Heart, Lung, And Blood Institute2004–2008
Administrative CoreNational Institute Of General Medical Sciences2007
Uw/Fhcrc Exploratory Center For Human ES Cell ResearchNational Institute Of General Medical Sciences2003–2006
Hemopoietic Stem Cell PlasticityNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2004
Proliferative Switch For Genetically Modified CellsNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2004
Proliferation % Differentiation Of Hemopoietic Stem CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2002
Core--ClinicalNational Heart, Lung, And Blood Institute2000–2002
Mixed Chimerism In The HemoglobinopathiesNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2002
Stem Cell Expansion Using Chemical Inducers Of Dimerization (CID)National Heart, Lung, And Blood Institute1999–2002
Effects Of Hydroxyurea In Sickle Cell DiseaseNational Center For Research Resources2000
Effects Of Hydroxyurea On Circulating Progenitors In Sickle Cell DiseaseNational Center For Research Resources1998–2000
Butyrate Response Elements Within The Beta-Globin LocusNational Institute Of Diabetes And Digestive And Kidney Diseases1994
Butyrate Response Elements Within The Beta Globin LocusNational Institute Of Diabetes And Digestive And Kidney Diseases1992